Skip to content

  • Who we are
    • About us
    • Members
    • Governance
    • FAQ
    • Donors
  • Research areas
        • Priority Research Questions
        • Post-COVID-19 condition
        • Lockdown impact on adolescent pregnancy
        • Working groups
        • Clinical Epidemiology
        • Clinical Management in Resource-limited Settings
        • Clinical Pharmacology & Drug Candidates
        • Data Management
        •  
        • Data Sharing
        • Ethics
        • Maternal, Newborn & Child Health
        • Regulatory
        •  
        • Social Science
        • Study Design & Analytics
        • Supply & Market Dynamics; Medicine Quality
        • Virology, Immunology & Diagnostics
  • Publications and Resources
    • Resources overview
    • Living Systematic Review
    • Member resources
    • Member publications
    • Protocol repository
  • News & events
    • News
    • Events
    • Viewpoints
    • Videos
    • Newsletter
  • Contact

Viewpoints

This section provides a space for coalition members to share short pieces that provide an expert opinion or a perspective on an issue related to COVID-19 clinical research.

If you would like to join the coalition, fill this form.

Read the viewpoint guidelines to find out how to submit a viewpoint.

Viewpoints
We need context-specific evidence to inform public health pandemic strategies in low-resource settings: A consideration of lockdowns
1 December 202112 January 2022
Nearly two years into the COVID-19 pandemic, Dr Wilber Sabiiti, co-chair of the coalition's Virology, Immunology and Diagnostics Working Group, makes a case for the need to strengthen context-specific evidence generation to guide pandemic strategies. In this Viewpoint, he looks at diverging approaches in Uganda and Tanzania, in their use of national lockdowns.
Read more →
Viewpoints
A TRIPS waiver is urgently needed to make progress on COVID-19 vaccine equity
15 July 202121 July 2021
The coalition's Social Science Working Group and co-signatories have published a viewpoint on vaccine equity, arguing that a temporary TRIPS waiver is needed for COVID-19 vaccines and other medicines. Vaccine inequity is amongst the most significant social justice issues of our generation, and it poses a major threat to the global COVID-19 response. Urgent action is needed to improve equity and bring an end to the COVID-19 pandemic, including in low- and middle-income countries.
Read more →
Hosted by
  • Privacy Policy
  • Terms of Use
  • Acceptable Use Policy
  • Cookie Policy

Newsletter

Get updates from the COVID-19 Clinical Research Coalition!
Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
By Gardeners